

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.64507510 |
| 2 | positive thymic T cell selection (GO:0045059) | 4.45297340 |
| 3 | mannose metabolic process (GO:0006013) | 4.27113387 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.23379525 |
| 5 | pre-miRNA processing (GO:0031054) | 4.16905122 |
| 6 | positive regulation of Rap GTPase activity (GO:0032854) | 3.88542182 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 3.82989191 |
| 8 | DNA unwinding involved in DNA replication (GO:0006268) | 3.80923460 |
| 9 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.74426529 |
| 10 | response to muramyl dipeptide (GO:0032495) | 3.69927220 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.68869464 |
| 12 | cellular hyperosmotic response (GO:0071474) | 3.62909607 |
| 13 | Peyers patch development (GO:0048541) | 3.62303578 |
| 14 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.62303578 |
| 15 | locomotory exploration behavior (GO:0035641) | 3.50814485 |
| 16 | peptidyl-arginine N-methylation (GO:0035246) | 3.50319617 |
| 17 | peptidyl-arginine methylation (GO:0018216) | 3.50319617 |
| 18 | ribosomal small subunit biogenesis (GO:0042274) | 3.42339749 |
| 19 | negative regulation of histone methylation (GO:0031061) | 3.34492581 |
| 20 | definitive hemopoiesis (GO:0060216) | 3.33107114 |
| 21 | regulation of female receptivity (GO:0045924) | 3.30423137 |
| 22 | response to peptidoglycan (GO:0032494) | 3.30276899 |
| 23 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.28991729 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.26227882 |
| 25 | regulation of Rap GTPase activity (GO:0032317) | 3.25738369 |
| 26 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.25192578 |
| 27 | thymic T cell selection (GO:0045061) | 3.25120977 |
| 28 | cerebellar granule cell differentiation (GO:0021707) | 3.20803771 |
| 29 | L-amino acid import (GO:0043092) | 3.14960490 |
| 30 | negative regulation of histone acetylation (GO:0035067) | 3.14777521 |
| 31 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.14692592 |
| 32 | histone arginine methylation (GO:0034969) | 3.14231227 |
| 33 | regulation of monocyte differentiation (GO:0045655) | 3.09612855 |
| 34 | protein-DNA complex disassembly (GO:0032986) | 3.09095089 |
| 35 | nucleosome disassembly (GO:0006337) | 3.09095089 |
| 36 | synaptic vesicle exocytosis (GO:0016079) | 2.99874841 |
| 37 | female mating behavior (GO:0060180) | 2.99769781 |
| 38 | positive T cell selection (GO:0043368) | 2.99764313 |
| 39 | peptidyl-arginine modification (GO:0018195) | 2.99345415 |
| 40 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.97819032 |
| 41 | regulation of leukocyte degranulation (GO:0043300) | 2.96733396 |
| 42 | positive regulation of synapse maturation (GO:0090129) | 2.96569422 |
| 43 | regulation of regulated secretory pathway (GO:1903305) | 2.96447143 |
| 44 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95285933 |
| 45 | neuromuscular process controlling posture (GO:0050884) | 2.95089875 |
| 46 | regulation of translational termination (GO:0006449) | 2.93472818 |
| 47 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.92834247 |
| 48 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.92651349 |
| 49 | negative regulation of microtubule polymerization (GO:0031115) | 2.91927716 |
| 50 | glutamate secretion (GO:0014047) | 2.89398508 |
| 51 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.89068133 |
| 52 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.88424462 |
| 53 | amino acid import (GO:0043090) | 2.87439349 |
| 54 | maturation of SSU-rRNA (GO:0030490) | 2.84565932 |
| 55 | layer formation in cerebral cortex (GO:0021819) | 2.83541194 |
| 56 | regulation of gamma-delta T cell activation (GO:0046643) | 2.81202223 |
| 57 | regulation of erythrocyte differentiation (GO:0045646) | 2.80665098 |
| 58 | ribosomal small subunit assembly (GO:0000028) | 2.79324182 |
| 59 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.77935242 |
| 60 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76690933 |
| 61 | cell migration in hindbrain (GO:0021535) | 2.75828078 |
| 62 | dopamine receptor signaling pathway (GO:0007212) | 2.75377424 |
| 63 | peptidyl-lysine dimethylation (GO:0018027) | 2.75101498 |
| 64 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.74894281 |
| 65 | regulation of response to osmotic stress (GO:0047484) | 2.74322255 |
| 66 | negative thymic T cell selection (GO:0045060) | 2.73227480 |
| 67 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.72842259 |
| 68 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.72461412 |
| 69 | neuronal action potential propagation (GO:0019227) | 2.71864691 |
| 70 | dendritic spine morphogenesis (GO:0060997) | 2.71380909 |
| 71 | B cell receptor signaling pathway (GO:0050853) | 2.71266105 |
| 72 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.71035028 |
| 73 | histone H4-K12 acetylation (GO:0043983) | 2.70805390 |
| 74 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.69933696 |
| 75 | negative regulation of histone modification (GO:0031057) | 2.69528876 |
| 76 | negative regulation of necrotic cell death (GO:0060547) | 2.66786534 |
| 77 | dosage compensation (GO:0007549) | 2.66242389 |
| 78 | modulation by virus of host process (GO:0019054) | 2.66169096 |
| 79 | regulation of B cell differentiation (GO:0045577) | 2.66094880 |
| 80 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.63980884 |
| 81 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.63762331 |
| 82 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.63581028 |
| 83 | positive regulation of granulocyte differentiation (GO:0030854) | 2.63246884 |
| 84 | negative regulation of granulocyte differentiation (GO:0030853) | 2.61607395 |
| 85 | negative regulation of type 2 immune response (GO:0002829) | 2.60824341 |
| 86 | natural killer cell differentiation (GO:0001779) | 2.59162288 |
| 87 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.57974570 |
| 88 | creatine metabolic process (GO:0006600) | 2.57691282 |
| 89 | sodium ion export (GO:0071436) | 2.57260964 |
| 90 | establishment of mitochondrion localization (GO:0051654) | 2.57111474 |
| 91 | T cell selection (GO:0045058) | 2.57102456 |
| 92 | cellular protein complex disassembly (GO:0043624) | 2.56943634 |
| 93 | negative regulation of RNA splicing (GO:0033119) | 2.56359424 |
| 94 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.55160610 |
| 95 | histone H4-K5 acetylation (GO:0043981) | 2.54601949 |
| 96 | histone H4-K8 acetylation (GO:0043982) | 2.54601949 |
| 97 | regulation of RNA export from nucleus (GO:0046831) | 2.53490301 |
| 98 | activation of JUN kinase activity (GO:0007257) | 2.52172754 |
| 99 | regulation of translational fidelity (GO:0006450) | 2.51688435 |
| 100 | protein complex localization (GO:0031503) | 2.51609037 |
| 101 | exploration behavior (GO:0035640) | 2.50830670 |
| 102 | regulation of granulocyte differentiation (GO:0030852) | 2.49892840 |
| 103 | viral transcription (GO:0019083) | 2.49651108 |
| 104 | regulation of mast cell degranulation (GO:0043304) | 2.48154524 |
| 105 | histone H2A acetylation (GO:0043968) | 2.47769706 |
| 106 | negative regulation of cell killing (GO:0031342) | 2.47219660 |
| 107 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.47219660 |
| 108 | viral life cycle (GO:0019058) | 2.46821287 |
| 109 | mitochondrion transport along microtubule (GO:0047497) | 2.45756452 |
| 110 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.45756452 |
| 111 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.45577274 |
| 112 | histone H3 deacetylation (GO:0070932) | 2.45382922 |
| 113 | membrane tubulation (GO:0097320) | 2.45016722 |
| 114 | regulation of ARF protein signal transduction (GO:0032012) | 2.44969166 |
| 115 | regulation of synaptic vesicle transport (GO:1902803) | 2.44491229 |
| 116 | central nervous system myelination (GO:0022010) | 2.43951032 |
| 117 | axon ensheathment in central nervous system (GO:0032291) | 2.43951032 |
| 118 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.43820997 |
| 119 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.43644901 |
| 120 | negative regulation of chromatin modification (GO:1903309) | 2.42646926 |
| 121 | regulation of synaptic plasticity (GO:0048167) | 2.42640118 |
| 122 | pinocytosis (GO:0006907) | 2.42324330 |
| 123 | negative regulation of B cell apoptotic process (GO:0002903) | 2.42066537 |
| 124 | translational termination (GO:0006415) | 2.41673269 |
| 125 | negative regulation of circadian rhythm (GO:0042754) | 2.41120391 |
| 126 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.40701714 |
| 127 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.40454142 |
| 128 | cellular extravasation (GO:0045123) | 2.40287415 |
| 129 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.38672059 |
| 130 | negative regulation of mRNA processing (GO:0050686) | 2.36657494 |
| 131 | histone H4 deacetylation (GO:0070933) | 2.36360470 |
| 132 | regulation of ARF GTPase activity (GO:0032312) | 2.34633871 |
| 133 | regulation of chromatin binding (GO:0035561) | 2.34460317 |
| 134 | regulation of helicase activity (GO:0051095) | 2.34205855 |
| 135 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.33466986 |
| 136 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.32801538 |
| 137 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.31791571 |
| 138 | DNA deamination (GO:0045006) | 2.30672372 |
| 139 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.30040641 |
| 140 | chromatin silencing (GO:0006342) | 2.29437342 |
| 141 | positive regulation of membrane potential (GO:0045838) | 2.27861667 |
| 142 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.27376047 |
| 143 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.26866222 |
| 144 | histone H4-K16 acetylation (GO:0043984) | 2.26291595 |
| 145 | neurotransmitter secretion (GO:0007269) | 2.26224042 |
| 146 | regulation of synapse structural plasticity (GO:0051823) | 2.26097123 |
| 147 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 2.25727507 |
| 148 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 2.25727507 |
| 149 | nodal signaling pathway (GO:0038092) | 2.25709399 |
| 150 | megakaryocyte development (GO:0035855) | 2.25363793 |
| 151 | histone H2A monoubiquitination (GO:0035518) | 2.25099109 |
| 152 | translational elongation (GO:0006414) | 2.24367610 |
| 153 | protein complex disassembly (GO:0043241) | 2.23637226 |
| 154 | neuromuscular process controlling balance (GO:0050885) | 2.23446127 |
| 155 | protein localization to synapse (GO:0035418) | 2.22024448 |
| 156 | histone H4 acetylation (GO:0043967) | 2.21812572 |
| 157 | microtubule severing (GO:0051013) | 2.20307598 |
| 158 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.18851840 |
| 159 | regulation of histone H3-K9 methylation (GO:0051570) | 2.18068164 |
| 160 | DNA replication initiation (GO:0006270) | 2.15936865 |
| 161 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.15812335 |
| 162 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.14661675 |
| 163 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.14622661 |
| 164 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.14622661 |
| 165 | negative regulation of mRNA metabolic process (GO:1903312) | 2.14314863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.28714581 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.59782439 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.00995767 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.85051535 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.52681616 |
| 6 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.49195256 |
| 7 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.39831842 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.34594155 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.33448913 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.22318234 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.16730883 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.16413644 |
| 13 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.14029947 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13834352 |
| 15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.05469176 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.03697010 |
| 17 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.00837910 |
| 18 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.99283325 |
| 19 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.92242125 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.90929330 |
| 21 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90167069 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89428436 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.88579268 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76347996 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75604770 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75513736 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73969025 |
| 28 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.73716929 |
| 29 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.71639986 |
| 30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.71484265 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.64185157 |
| 32 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.62806853 |
| 33 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.62073690 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61410172 |
| 35 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.59342804 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59198457 |
| 37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.54109074 |
| 38 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.53793374 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.52121742 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50515413 |
| 41 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.47662211 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.47642919 |
| 43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47629450 |
| 44 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.46382909 |
| 45 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.45396284 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.44219345 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43710461 |
| 48 | * P68_20966046_ChIP-Seq_HELA_Human | 1.43579011 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41177670 |
| 50 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.41001049 |
| 51 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.38625904 |
| 52 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.38452766 |
| 53 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.37810878 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36377878 |
| 55 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.35901993 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34847317 |
| 57 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34804791 |
| 58 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34732703 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34660944 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34451112 |
| 61 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.33373440 |
| 62 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.32727271 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32727264 |
| 64 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.32419821 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32364328 |
| 66 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.31650779 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30532362 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.29889359 |
| 69 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.29823463 |
| 70 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.28430110 |
| 71 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.28042254 |
| 72 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.26736716 |
| 73 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.25437872 |
| 74 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25394939 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24362276 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.23845053 |
| 77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23329083 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22882911 |
| 79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.22659281 |
| 80 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.22526455 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21895487 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21888304 |
| 83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21497446 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20907215 |
| 85 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20504171 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20014377 |
| 87 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19264917 |
| 88 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.18890655 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18288437 |
| 90 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18239365 |
| 91 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.18086667 |
| 92 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.17132450 |
| 93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16732276 |
| 94 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.16448622 |
| 95 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15739460 |
| 96 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15673063 |
| 97 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15172413 |
| 98 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.15036467 |
| 99 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14256703 |
| 100 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13988982 |
| 101 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13846749 |
| 102 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.13567678 |
| 103 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.13252933 |
| 104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13189718 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12987901 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12288389 |
| 107 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11051044 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10782527 |
| 109 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.09657706 |
| 110 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08756782 |
| 111 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08576677 |
| 112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08530869 |
| 113 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08321629 |
| 114 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08167404 |
| 115 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.07023431 |
| 116 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06715340 |
| 117 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.06136780 |
| 118 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.06059529 |
| 119 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.04287601 |
| 120 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03194950 |
| 121 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03116464 |
| 122 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02405715 |
| 123 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.00063285 |
| 124 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99831188 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99285294 |
| 126 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98394056 |
| 127 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98347673 |
| 128 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.98303752 |
| 129 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98177953 |
| 130 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.98091396 |
| 131 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.96926833 |
| 132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96904614 |
| 133 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96904233 |
| 134 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96815122 |
| 135 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96495739 |
| 136 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95609697 |
| 137 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95349777 |
| 138 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.93234209 |
| 139 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.93219986 |
| 140 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92703652 |
| 141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92668187 |
| 142 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.92180174 |
| 143 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91828416 |
| 144 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91633063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.12386356 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 2.75389090 |
| 3 | MP0003436_decreased_susceptibility_to | 2.75094768 |
| 4 | MP0004270_analgesia | 2.73690063 |
| 5 | MP0003303_peritoneal_inflammation | 2.70963033 |
| 6 | MP0003693_abnormal_embryo_hatching | 2.49879113 |
| 7 | MP0002653_abnormal_ependyma_morphology | 2.49786529 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.37867926 |
| 9 | MP0003880_abnormal_central_pattern | 2.35107676 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.14752813 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.05965425 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.01955844 |
| 13 | MP0009379_abnormal_foot_pigmentation | 1.99692105 |
| 14 | MP0002064_seizures | 1.93748108 |
| 15 | MP0003077_abnormal_cell_cycle | 1.91525944 |
| 16 | MP0003111_abnormal_nucleus_morphology | 1.91071765 |
| 17 | MP0003690_abnormal_glial_cell | 1.90781313 |
| 18 | MP0003123_paternal_imprinting | 1.88811407 |
| 19 | MP0008260_abnormal_autophagy | 1.87502650 |
| 20 | MP0002396_abnormal_hematopoietic_system | 1.87045280 |
| 21 | MP0004957_abnormal_blastocyst_morpholog | 1.83380331 |
| 22 | MP0001486_abnormal_startle_reflex | 1.82033450 |
| 23 | MP0009745_abnormal_behavioral_response | 1.74165881 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.73500812 |
| 25 | MP0005423_abnormal_somatic_nervous | 1.73174786 |
| 26 | MP0002272_abnormal_nervous_system | 1.67851858 |
| 27 | MP0005174_abnormal_tail_pigmentation | 1.65259848 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.62686504 |
| 29 | MP0009046_muscle_twitch | 1.60604352 |
| 30 | MP0001730_embryonic_growth_arrest | 1.57726261 |
| 31 | MP0008057_abnormal_DNA_replication | 1.56199312 |
| 32 | MP0005451_abnormal_body_composition | 1.53613022 |
| 33 | MP0004133_heterotaxia | 1.51275249 |
| 34 | MP0004885_abnormal_endolymph | 1.50558128 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.47141051 |
| 36 | MP0005025_abnormal_response_to | 1.46778941 |
| 37 | MP0000604_amyloidosis | 1.46711574 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.42833450 |
| 39 | MP0000955_abnormal_spinal_cord | 1.42102756 |
| 40 | MP0003075_altered_response_to | 1.40900367 |
| 41 | MP0001968_abnormal_touch/_nociception | 1.38585520 |
| 42 | MP0003787_abnormal_imprinting | 1.37604497 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.37221671 |
| 44 | MP0002419_abnormal_innate_immunity | 1.36941819 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.34881577 |
| 46 | MP0008569_lethality_at_weaning | 1.34518323 |
| 47 | MP0003121_genomic_imprinting | 1.34125469 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.33394190 |
| 49 | MP0001835_abnormal_antigen_presentation | 1.32584436 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.32275744 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.31955076 |
| 52 | MP0002249_abnormal_larynx_morphology | 1.30300102 |
| 53 | MP0001819_abnormal_immune_cell | 1.30277010 |
| 54 | MP0002084_abnormal_developmental_patter | 1.29873927 |
| 55 | MP0001529_abnormal_vocalization | 1.29537307 |
| 56 | MP0000350_abnormal_cell_proliferation | 1.26972752 |
| 57 | MP0002132_abnormal_respiratory_system | 1.26679035 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.25898312 |
| 59 | MP0002734_abnormal_mechanical_nocicepti | 1.25867154 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.24682176 |
| 61 | MP0003122_maternal_imprinting | 1.22696769 |
| 62 | MP0003861_abnormal_nervous_system | 1.21815432 |
| 63 | MP0000716_abnormal_immune_system | 1.21691654 |
| 64 | MP0009278_abnormal_bone_marrow | 1.20860420 |
| 65 | MP0005410_abnormal_fertilization | 1.18508451 |
| 66 | MP0002822_catalepsy | 1.17873617 |
| 67 | MP0002152_abnormal_brain_morphology | 1.17784728 |
| 68 | MP0002085_abnormal_embryonic_tissue | 1.17628637 |
| 69 | MP0000685_abnormal_immune_system | 1.17399494 |
| 70 | MP0006292_abnormal_olfactory_placode | 1.15912226 |
| 71 | MP0002882_abnormal_neuron_morphology | 1.14678693 |
| 72 | MP0001800_abnormal_humoral_immune | 1.14179744 |
| 73 | MP0002723_abnormal_immune_serum | 1.12838007 |
| 74 | MP0005394_taste/olfaction_phenotype | 1.12729125 |
| 75 | MP0005499_abnormal_olfactory_system | 1.12729125 |
| 76 | MP0001929_abnormal_gametogenesis | 1.11327278 |
| 77 | MP0002429_abnormal_blood_cell | 1.11241053 |
| 78 | MP0000681_abnormal_thyroid_gland | 1.10849169 |
| 79 | MP0003879_abnormal_hair_cell | 1.10038355 |
| 80 | MP0002722_abnormal_immune_system | 1.09387879 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 1.08558682 |
| 82 | MP0008007_abnormal_cellular_replicative | 1.07414541 |
| 83 | MP0009672_abnormal_birth_weight | 1.07016627 |
| 84 | MP0004742_abnormal_vestibular_system | 1.07003287 |
| 85 | MP0000703_abnormal_thymus_morphology | 1.06956766 |
| 86 | MP0003329_amyloid_beta_deposits | 1.05976499 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 1.05315902 |
| 88 | MP0001970_abnormal_pain_threshold | 1.04840950 |
| 89 | MP0003634_abnormal_glial_cell | 1.04422563 |
| 90 | MP0000778_abnormal_nervous_system | 1.04230564 |
| 91 | MP0000689_abnormal_spleen_morphology | 1.02816111 |
| 92 | MP0002210_abnormal_sex_determination | 1.01186795 |
| 93 | MP0002398_abnormal_bone_marrow | 1.01117891 |
| 94 | MP0002557_abnormal_social/conspecific_i | 1.00739072 |
| 95 | MP0008770_decreased_survivor_rate | 1.00717400 |
| 96 | MP0003763_abnormal_thymus_physiology | 1.00308953 |
| 97 | MP0004142_abnormal_muscle_tone | 0.99920272 |
| 98 | MP0005397_hematopoietic_system_phenotyp | 0.99607975 |
| 99 | MP0001545_abnormal_hematopoietic_system | 0.99607975 |
| 100 | MP0001851_eye_inflammation | 0.99128700 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.98964809 |
| 102 | MP0002066_abnormal_motor_capabilities/c | 0.98598779 |
| 103 | MP0004924_abnormal_behavior | 0.98597044 |
| 104 | MP0005386_behavior/neurological_phenoty | 0.98597044 |
| 105 | MP0001790_abnormal_immune_system | 0.98193638 |
| 106 | MP0005387_immune_system_phenotype | 0.98193638 |
| 107 | MP0002405_respiratory_system_inflammati | 0.98151559 |
| 108 | MP0002452_abnormal_antigen_presenting | 0.97222497 |
| 109 | MP0001849_ear_inflammation | 0.97058307 |
| 110 | MP0003698_abnormal_male_reproductive | 0.94947053 |
| 111 | MP0001697_abnormal_embryo_size | 0.94365088 |
| 112 | MP0003866_abnormal_defecation | 0.94109880 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.93418974 |
| 114 | MP0008058_abnormal_DNA_repair | 0.93336756 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.93222161 |
| 116 | MP0001905_abnormal_dopamine_level | 0.92948399 |
| 117 | MP0002080_prenatal_lethality | 0.92800089 |
| 118 | MP0002733_abnormal_thermal_nociception | 0.92748361 |
| 119 | MP0000537_abnormal_urethra_morphology | 0.91003897 |
| 120 | MP0009840_abnormal_foam_cell | 0.90288497 |
| 121 | MP0003633_abnormal_nervous_system | 0.90024491 |
| 122 | MP0009333_abnormal_splenocyte_physiolog | 0.89732627 |
| 123 | MP0001145_abnormal_male_reproductive | 0.89591800 |
| 124 | MP0001502_abnormal_circadian_rhythm | 0.89180448 |
| 125 | MP0000490_abnormal_crypts_of | 0.88440452 |
| 126 | MP0001440_abnormal_grooming_behavior | 0.88033623 |
| 127 | MP0001853_heart_inflammation | 0.87601709 |
| 128 | MP0002067_abnormal_sensory_capabilities | 0.87296943 |
| 129 | MP0000313_abnormal_cell_death | 0.87285202 |
| 130 | MP0004233_abnormal_muscle_weight | 0.85477405 |
| 131 | MP0004130_abnormal_muscle_cell | 0.84615767 |
| 132 | MP0000653_abnormal_sex_gland | 0.84506742 |
| 133 | MP0002184_abnormal_innervation | 0.84194115 |
| 134 | MP0000631_abnormal_neuroendocrine_gland | 0.83915982 |
| 135 | MP0005535_abnormal_body_temperature | 0.83507643 |
| 136 | MP0004947_skin_inflammation | 0.83338997 |
| 137 | MP0003646_muscle_fatigue | 0.82912627 |
| 138 | MP0000920_abnormal_myelination | 0.82370462 |
| 139 | MP0002089_abnormal_postnatal_growth/wei | 0.81675804 |
| 140 | MP0002735_abnormal_chemical_nociception | 0.80748823 |
| 141 | MP0003631_nervous_system_phenotype | 0.80671689 |
| 142 | MP0005075_abnormal_melanosome_morpholog | 0.80062898 |
| 143 | MP0003656_abnormal_erythrocyte_physiolo | 0.79689817 |
| 144 | MP0004858_abnormal_nervous_system | 0.79686306 |
| 145 | MP0003172_abnormal_lysosome_physiology | 0.79495262 |
| 146 | MP0002161_abnormal_fertility/fecundity | 0.79300281 |
| 147 | MP0001672_abnormal_embryogenesis/_devel | 0.78871944 |
| 148 | MP0005380_embryogenesis_phenotype | 0.78871944 |
| 149 | MP0002736_abnormal_nociception_after | 0.78013023 |
| 150 | MP0008872_abnormal_physiological_respon | 0.77964443 |
| 151 | MP0002019_abnormal_tumor_incidence | 0.77098330 |
| 152 | MP0005409_darkened_coat_color | 0.76993409 |
| 153 | MP0008874_decreased_physiological_sensi | 0.76009929 |
| 154 | MP0001533_abnormal_skeleton_physiology | 0.75392432 |
| 155 | MP0002102_abnormal_ear_morphology | 0.75348520 |
| 156 | MP0000747_muscle_weakness | 0.74337046 |
| 157 | MP0001348_abnormal_lacrimal_gland | 0.73946533 |
| 158 | MP0001873_stomach_inflammation | 0.73118450 |
| 159 | MP0000678_abnormal_parathyroid_gland | 0.72847100 |
| 160 | MP0001986_abnormal_taste_sensitivity | 0.72076479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperacusis (HP:0010780) | 4.68779622 |
| 2 | Myokymia (HP:0002411) | 3.92140026 |
| 3 | Insomnia (HP:0100785) | 3.55718440 |
| 4 | Cellulitis (HP:0100658) | 3.31895593 |
| 5 | Visual hallucinations (HP:0002367) | 3.30651723 |
| 6 | Abnormality of binocular vision (HP:0011514) | 3.28672575 |
| 7 | Diplopia (HP:0000651) | 3.28672575 |
| 8 | Overriding aorta (HP:0002623) | 3.20897476 |
| 9 | Annular pancreas (HP:0001734) | 3.14246082 |
| 10 | Neurofibrillary tangles (HP:0002185) | 3.05850803 |
| 11 | Obstructive sleep apnea (HP:0002870) | 3.05582990 |
| 12 | Pointed chin (HP:0000307) | 2.88243754 |
| 13 | Obstructive lung disease (HP:0006536) | 2.87954625 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87954625 |
| 15 | Papilledema (HP:0001085) | 2.85972325 |
| 16 | Ankle clonus (HP:0011448) | 2.81994712 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.81643091 |
| 18 | Agammaglobulinemia (HP:0004432) | 2.79797046 |
| 19 | Focal seizures (HP:0007359) | 2.77928925 |
| 20 | Urinary urgency (HP:0000012) | 2.76519065 |
| 21 | Cerebral hypomyelination (HP:0006808) | 2.75390529 |
| 22 | Elfin facies (HP:0004428) | 2.70976872 |
| 23 | Focal motor seizures (HP:0011153) | 2.70152504 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 2.69784588 |
| 25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.63870567 |
| 26 | Acute lymphatic leukemia (HP:0006721) | 2.63659480 |
| 27 | Spastic gait (HP:0002064) | 2.63085973 |
| 28 | Progressive inability to walk (HP:0002505) | 2.61900976 |
| 29 | Asplenia (HP:0001746) | 2.61819171 |
| 30 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.56223172 |
| 31 | Polygenic inheritance (HP:0010982) | 2.56022824 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.55424743 |
| 33 | Eczematoid dermatitis (HP:0000976) | 2.55220586 |
| 34 | Supranuclear gaze palsy (HP:0000605) | 2.54091576 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54086398 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.51809981 |
| 37 | Peripheral hypomyelination (HP:0007182) | 2.49282156 |
| 38 | Renal duplication (HP:0000075) | 2.49232854 |
| 39 | Truncus arteriosus (HP:0001660) | 2.47662362 |
| 40 | Flat cornea (HP:0007720) | 2.45811470 |
| 41 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.43972439 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 2.42153591 |
| 43 | Thoracic kyphosis (HP:0002942) | 2.38571551 |
| 44 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.38525507 |
| 45 | Ragged-red muscle fibers (HP:0003200) | 2.38129442 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.34297731 |
| 47 | Bowel incontinence (HP:0002607) | 2.32305217 |
| 48 | Increased nuchal translucency (HP:0010880) | 2.32131522 |
| 49 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.31297223 |
| 50 | Ependymoma (HP:0002888) | 2.28419685 |
| 51 | Poor eye contact (HP:0000817) | 2.27969374 |
| 52 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.27955651 |
| 53 | Renovascular hypertension (HP:0100817) | 2.27895869 |
| 54 | Basal cell carcinoma (HP:0002671) | 2.27392284 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.26333367 |
| 56 | Hyperthyroidism (HP:0000836) | 2.26048080 |
| 57 | Slow saccadic eye movements (HP:0000514) | 2.24973921 |
| 58 | Hypertensive crisis (HP:0100735) | 2.24783594 |
| 59 | Megalocornea (HP:0000485) | 2.24709771 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.23659513 |
| 61 | Recurrent fungal infections (HP:0002841) | 2.23573547 |
| 62 | Depression (HP:0000716) | 2.23412346 |
| 63 | Meningitis (HP:0001287) | 2.21456830 |
| 64 | Colitis (HP:0002583) | 2.20346885 |
| 65 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.19726817 |
| 66 | Panhypogammaglobulinemia (HP:0003139) | 2.19523402 |
| 67 | Neoplasm of the oral cavity (HP:0100649) | 2.18428350 |
| 68 | Exercise-induced myalgia (HP:0003738) | 2.17932206 |
| 69 | Abnormal large intestine physiology (HP:0012700) | 2.15135961 |
| 70 | Foot dorsiflexor weakness (HP:0009027) | 2.14136125 |
| 71 | Abnormality of the diencephalon (HP:0010662) | 2.13801090 |
| 72 | Abnormality of the labia minora (HP:0012880) | 2.12581746 |
| 73 | Seborrheic dermatitis (HP:0001051) | 2.11965473 |
| 74 | Pallor (HP:0000980) | 2.09863087 |
| 75 | Sacral dimple (HP:0000960) | 2.09590136 |
| 76 | Increased IgE level (HP:0003212) | 2.09563365 |
| 77 | Dysmetric saccades (HP:0000641) | 2.07085086 |
| 78 | Microvesicular hepatic steatosis (HP:0001414) | 2.06963802 |
| 79 | Diminished motivation (HP:0000745) | 2.06879661 |
| 80 | Broad-based gait (HP:0002136) | 2.05979246 |
| 81 | Progressive muscle weakness (HP:0003323) | 2.05469205 |
| 82 | Premature skin wrinkling (HP:0100678) | 2.04999343 |
| 83 | Mutism (HP:0002300) | 2.04670549 |
| 84 | Abnormality of the corticospinal tract (HP:0002492) | 2.03816435 |
| 85 | Abnormality of saccadic eye movements (HP:0000570) | 2.03121837 |
| 86 | Onion bulb formation (HP:0003383) | 2.03102077 |
| 87 | Apathy (HP:0000741) | 2.03031010 |
| 88 | Abnormality of the thoracic spine (HP:0100711) | 2.02013359 |
| 89 | Deep palmar crease (HP:0006191) | 2.01797244 |
| 90 | Myositis (HP:0100614) | 2.00455842 |
| 91 | Medulloblastoma (HP:0002885) | 2.00364174 |
| 92 | Abnormal number of erythroid precursors (HP:0012131) | 1.99896304 |
| 93 | Impaired smooth pursuit (HP:0007772) | 1.99513911 |
| 94 | Muscle stiffness (HP:0003552) | 1.99365885 |
| 95 | Supernumerary spleens (HP:0009799) | 1.99362725 |
| 96 | Postural instability (HP:0002172) | 1.98757123 |
| 97 | Lower limb asymmetry (HP:0100559) | 1.98677337 |
| 98 | Amyotrophic lateral sclerosis (HP:0007354) | 1.98061097 |
| 99 | Recurrent abscess formation (HP:0002722) | 1.98058321 |
| 100 | Epileptic encephalopathy (HP:0200134) | 1.98030916 |
| 101 | Abnormal social behavior (HP:0012433) | 1.95617275 |
| 102 | Impaired social interactions (HP:0000735) | 1.95617275 |
| 103 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.94857022 |
| 104 | Recurrent cutaneous fungal infections (HP:0011370) | 1.94857022 |
| 105 | Esophageal atresia (HP:0002032) | 1.94855533 |
| 106 | Nonprogressive disorder (HP:0003680) | 1.94712771 |
| 107 | Nasal polyposis (HP:0100582) | 1.94114171 |
| 108 | Abnormality of the foot musculature (HP:0001436) | 1.92743115 |
| 109 | Termporal pattern (HP:0011008) | 1.92725902 |
| 110 | Insidious onset (HP:0003587) | 1.92725902 |
| 111 | Dysmetria (HP:0001310) | 1.92243053 |
| 112 | Atonic seizures (HP:0010819) | 1.91030767 |
| 113 | Tented upper lip vermilion (HP:0010804) | 1.90032792 |
| 114 | CNS hypomyelination (HP:0003429) | 1.89944682 |
| 115 | Achilles tendon contracture (HP:0001771) | 1.89931546 |
| 116 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.89244626 |
| 117 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.89244626 |
| 118 | Intention tremor (HP:0002080) | 1.89057003 |
| 119 | Recurrent bacterial skin infections (HP:0005406) | 1.88514528 |
| 120 | Abnormality of the fingertips (HP:0001211) | 1.87694596 |
| 121 | Facial hemangioma (HP:0000329) | 1.87643505 |
| 122 | Tetraplegia (HP:0002445) | 1.87108509 |
| 123 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.86432340 |
| 124 | Reticulocytopenia (HP:0001896) | 1.86108471 |
| 125 | Febrile seizures (HP:0002373) | 1.85801329 |
| 126 | Myopathic facies (HP:0002058) | 1.85718395 |
| 127 | Truncal ataxia (HP:0002078) | 1.84419053 |
| 128 | Recurrent viral infections (HP:0004429) | 1.83932063 |
| 129 | Dysostosis multiplex (HP:0000943) | 1.83896030 |
| 130 | Aplastic anemia (HP:0001915) | 1.83888000 |
| 131 | Rigidity (HP:0002063) | 1.82837005 |
| 132 | Dysphonia (HP:0001618) | 1.82590863 |
| 133 | Abnormality of the musculature of the hand (HP:0001421) | 1.82091061 |
| 134 | Abnormality of the nasal mucosa (HP:0000433) | 1.81717768 |
| 135 | Stereotypic behavior (HP:0000733) | 1.81597016 |
| 136 | Generalized hypotonia (HP:0001290) | 1.79785718 |
| 137 | Athetosis (HP:0002305) | 1.78627909 |
| 138 | Obsessive-compulsive behavior (HP:0000722) | 1.77911601 |
| 139 | Abnormality of the periventricular white matter (HP:0002518) | 1.77471398 |
| 140 | Epistaxis (HP:0000421) | 1.77411194 |
| 141 | Rib fusion (HP:0000902) | 1.75029344 |
| 142 | Attention deficit hyperactivity disorder (HP:0007018) | 1.74886456 |
| 143 | Genetic anticipation (HP:0003743) | 1.74089601 |
| 144 | Inappropriate behavior (HP:0000719) | 1.73288439 |
| 145 | Gaze-evoked nystagmus (HP:0000640) | 1.70724285 |
| 146 | Abnormality of the astrocytes (HP:0100707) | 1.70606430 |
| 147 | Astrocytoma (HP:0009592) | 1.70606430 |
| 148 | Prominent nose (HP:0000448) | 1.69536344 |
| 149 | Chronic otitis media (HP:0000389) | 1.66826878 |
| 150 | Hemiplegia (HP:0002301) | 1.65090683 |
| 151 | Abnormality of the carotid arteries (HP:0005344) | 1.63364624 |
| 152 | Colon cancer (HP:0003003) | 1.61176727 |
| 153 | Male infertility (HP:0003251) | 1.60697575 |
| 154 | Thrombocytosis (HP:0001894) | 1.60506072 |
| 155 | Bradykinesia (HP:0002067) | 1.59622566 |
| 156 | Clonus (HP:0002169) | 1.58346016 |
| 157 | Neuronal loss in central nervous system (HP:0002529) | 1.58302624 |
| 158 | Macroorchidism (HP:0000053) | 1.58084122 |
| 159 | High anterior hairline (HP:0009890) | 1.57923522 |
| 160 | Neoplasm of striated muscle (HP:0009728) | 1.55710041 |
| 161 | Heterotopia (HP:0002282) | 1.54470143 |
| 162 | Acute myeloid leukemia (HP:0004808) | 1.51499901 |
| 163 | Action tremor (HP:0002345) | 1.51488329 |
| 164 | Abnormality of chromosome segregation (HP:0002916) | 1.50965174 |
| 165 | Rapidly progressive (HP:0003678) | 1.49263831 |
| 166 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.49139836 |
| 167 | Neoplasm of the heart (HP:0100544) | 1.47497046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.02428512 |
| 2 | PRPF4B | 3.75665705 |
| 3 | CDK19 | 3.27317151 |
| 4 | ERN1 | 3.12588438 |
| 5 | MAP3K9 | 3.04695345 |
| 6 | TYRO3 | 2.63595969 |
| 7 | RIPK4 | 2.51517612 |
| 8 | SMG1 | 2.45649874 |
| 9 | PRKD3 | 2.43453681 |
| 10 | ICK | 2.32601272 |
| 11 | KSR2 | 2.22380000 |
| 12 | MAP3K11 | 2.15860953 |
| 13 | NTRK2 | 1.90212449 |
| 14 | MAP3K4 | 1.79718230 |
| 15 | TAOK1 | 1.79299139 |
| 16 | CDC7 | 1.75465845 |
| 17 | UHMK1 | 1.71215309 |
| 18 | SCYL2 | 1.70928041 |
| 19 | PAK6 | 1.65675869 |
| 20 | DAPK1 | 1.56576265 |
| 21 | MAP3K6 | 1.51453542 |
| 22 | ALK | 1.50966024 |
| 23 | MAP2K3 | 1.46983231 |
| 24 | HIPK2 | 1.43039487 |
| 25 | MINK1 | 1.41110111 |
| 26 | PKN2 | 1.39312814 |
| 27 | MAP3K1 | 1.37757390 |
| 28 | MAP3K10 | 1.37715926 |
| 29 | MAPKAPK5 | 1.37455474 |
| 30 | KSR1 | 1.35771866 |
| 31 | MAPKAPK3 | 1.34148546 |
| 32 | NTRK3 | 1.29501795 |
| 33 | RAF1 | 1.23588026 |
| 34 | EPHA4 | 1.23548691 |
| 35 | NME2 | 1.22001530 |
| 36 | RIPK1 | 1.21149781 |
| 37 | CAMKK1 | 1.21008838 |
| 38 | MUSK | 1.20208727 |
| 39 | CDK12 | 1.17702059 |
| 40 | MAP3K12 | 1.15536091 |
| 41 | MAP4K1 | 1.13580839 |
| 42 | MAPK12 | 1.12988400 |
| 43 | SIK1 | 1.11586023 |
| 44 | PNCK | 1.10939861 |
| 45 | TRIB3 | 1.09669644 |
| 46 | TBK1 | 1.09161505 |
| 47 | MARK2 | 1.08976716 |
| 48 | RET | 1.07654098 |
| 49 | KIT | 1.05681189 |
| 50 | LRRK2 | 1.03904929 |
| 51 | PASK | 1.03890630 |
| 52 | BCKDK | 1.02801380 |
| 53 | NEK2 | 1.01153691 |
| 54 | FES | 1.00185125 |
| 55 | BRSK1 | 0.99341530 |
| 56 | IRAK3 | 0.98038780 |
| 57 | PDPK1 | 0.97345737 |
| 58 | TAOK3 | 0.95391291 |
| 59 | IRAK2 | 0.95242360 |
| 60 | MAP2K2 | 0.94400113 |
| 61 | MAP2K7 | 0.93194253 |
| 62 | TAOK2 | 0.93152758 |
| 63 | BUB1 | 0.92641647 |
| 64 | WEE1 | 0.91447176 |
| 65 | SIK2 | 0.91029025 |
| 66 | PRKD2 | 0.87068212 |
| 67 | MARK1 | 0.86438591 |
| 68 | MAP2K4 | 0.86244131 |
| 69 | MAPK15 | 0.85543928 |
| 70 | STK38 | 0.85344230 |
| 71 | MAP3K13 | 0.84921851 |
| 72 | VRK1 | 0.83070376 |
| 73 | CDK11A | 0.81945820 |
| 74 | TIE1 | 0.81683671 |
| 75 | MAP3K7 | 0.77860409 |
| 76 | CLK1 | 0.77787295 |
| 77 | CDK15 | 0.77732124 |
| 78 | CDK18 | 0.77526752 |
| 79 | CDK5 | 0.77223359 |
| 80 | SYK | 0.76124672 |
| 81 | FGFR2 | 0.75605342 |
| 82 | GRK6 | 0.75550193 |
| 83 | CAMK1 | 0.75253814 |
| 84 | PRKG2 | 0.74948615 |
| 85 | RPS6KL1 | 0.74080449 |
| 86 | RPS6KC1 | 0.74080449 |
| 87 | TESK2 | 0.73893193 |
| 88 | BRD4 | 0.71901614 |
| 89 | JAK3 | 0.70441708 |
| 90 | DAPK2 | 0.70400412 |
| 91 | TTK | 0.70161102 |
| 92 | CSNK1G3 | 0.70152867 |
| 93 | BTK | 0.70078347 |
| 94 | MAPK11 | 0.69317667 |
| 95 | TGFBR1 | 0.69235250 |
| 96 | CDK14 | 0.68490535 |
| 97 | CDK4 | 0.67981003 |
| 98 | RPS6KB2 | 0.66701172 |
| 99 | PRKCH | 0.65242961 |
| 100 | CSNK1G2 | 0.65136274 |
| 101 | FLT3 | 0.64484043 |
| 102 | VRK2 | 0.63300373 |
| 103 | TNK2 | 0.62883579 |
| 104 | ZAP70 | 0.62107089 |
| 105 | PDK1 | 0.61445760 |
| 106 | MAP3K8 | 0.61297771 |
| 107 | RPS6KA2 | 0.60999587 |
| 108 | MAPK10 | 0.60544338 |
| 109 | MAPK13 | 0.59542860 |
| 110 | BMX | 0.59100888 |
| 111 | STK11 | 0.58481702 |
| 112 | RPS6KA6 | 0.58460779 |
| 113 | LATS2 | 0.58035427 |
| 114 | CHEK2 | 0.57548083 |
| 115 | CHEK1 | 0.57083269 |
| 116 | CDK7 | 0.56812161 |
| 117 | IRAK4 | 0.55592352 |
| 118 | MAP2K6 | 0.55451849 |
| 119 | ARAF | 0.54362662 |
| 120 | CAMK4 | 0.54157719 |
| 121 | ATR | 0.53763261 |
| 122 | CDK2 | 0.53486298 |
| 123 | MAPK4 | 0.53449249 |
| 124 | CAMK1D | 0.52713829 |
| 125 | CSF1R | 0.52652937 |
| 126 | HCK | 0.52282921 |
| 127 | AKT2 | 0.51300307 |
| 128 | NTRK1 | 0.50862427 |
| 129 | CDC42BPA | 0.49633554 |
| 130 | CDK9 | 0.49341274 |
| 131 | STK10 | 0.48873406 |
| 132 | ITK | 0.46466236 |
| 133 | DYRK1A | 0.45627935 |
| 134 | FGFR4 | 0.45061073 |
| 135 | MAP3K2 | 0.44179659 |
| 136 | MAPK3 | 0.44088198 |
| 137 | RPS6KA1 | 0.43820781 |
| 138 | CSNK1E | 0.43692925 |
| 139 | MTOR | 0.43508183 |
| 140 | JAK2 | 0.42732252 |
| 141 | DYRK3 | 0.42111398 |
| 142 | CSNK1A1L | 0.42063715 |
| 143 | WNK1 | 0.42027537 |
| 144 | MATK | 0.40913268 |
| 145 | TNIK | 0.40901182 |
| 146 | LIMK1 | 0.40577705 |
| 147 | MAPK8 | 0.40461252 |
| 148 | DYRK1B | 0.37579080 |
| 149 | DAPK3 | 0.36607699 |
| 150 | LCK | 0.36399110 |
| 151 | TYK2 | 0.36398950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.54220027 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.27268855 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.03166662 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 1.88377246 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 1.82696777 |
| 6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.74952089 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.65348924 |
| 8 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.62038257 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61805097 |
| 10 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.54462375 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 1.53205237 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.51952249 |
| 13 | Colorectal cancer_Homo sapiens_hsa05210 | 1.48838570 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.47223062 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 1.45601321 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.45385078 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.44393674 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44282161 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40328196 |
| 20 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.39058162 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.37742265 |
| 22 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.33154124 |
| 23 | RNA transport_Homo sapiens_hsa03013 | 1.32957010 |
| 24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.29825685 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29503740 |
| 26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.29285129 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28724604 |
| 28 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27704108 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.26784093 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.25011931 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.21668085 |
| 32 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21325812 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19565468 |
| 34 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.18815817 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.18559951 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17875687 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.17666731 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.16519503 |
| 39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.16190924 |
| 40 | GABAergic synapse_Homo sapiens_hsa04727 | 1.14909541 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.14198480 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13241054 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.12780911 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11465431 |
| 45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.10046074 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09484551 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07727021 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.07726970 |
| 49 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.05526421 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04933838 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04742067 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 1.04319115 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04318583 |
| 54 | Ribosome_Homo sapiens_hsa03010 | 1.03576555 |
| 55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.00043888 |
| 56 | Alcoholism_Homo sapiens_hsa05034 | 0.99792442 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97789939 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.97189266 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96074449 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95924683 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93821494 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92481642 |
| 63 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.92188568 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91229803 |
| 65 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89785726 |
| 66 | Axon guidance_Homo sapiens_hsa04360 | 0.88434254 |
| 67 | Homologous recombination_Homo sapiens_hsa03440 | 0.88321579 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.87454487 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.87426312 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.87253995 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87011462 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.84624657 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83730941 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83064449 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.82814097 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.82624210 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.82599298 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82393491 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82244912 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81339373 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81265456 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80534521 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80265549 |
| 84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80184113 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79077827 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78231081 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77636834 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77319782 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.76564590 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76016311 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75531268 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.74990418 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74698624 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73901737 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73427941 |
| 96 | Allograft rejection_Homo sapiens_hsa05330 | 0.71429920 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70219369 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.69936709 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.69648863 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69117345 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.69052173 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66120547 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65945790 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.65858946 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64552283 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64012512 |
| 107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63920188 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63051854 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62946164 |
| 110 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62249362 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62059366 |
| 112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61922950 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61318531 |
| 114 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59884050 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59874866 |
| 116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59353817 |
| 117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58381224 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57335519 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57290032 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57062024 |
| 121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55827536 |
| 122 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55770046 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54430283 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54025937 |
| 125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53731730 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.53437193 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52831498 |
| 128 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.52655481 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.52190992 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51853063 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51809975 |
| 132 | Pathways in cancer_Homo sapiens_hsa05200 | 0.51514622 |
| 133 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50772851 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | 0.50689292 |
| 135 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50294552 |

